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OBJECTIVE—To investigate whether a single nucleotide poly-
morphism (SNP) in the mitochondrial gene for NADH dehydro-
genase 2 (mt-Nd2) can modulate susceptibility to type 1 diabetes
in NOD mice.
RESEARCH DESIGN AND METHODS—NOD/ShiLtJ mice
conplastic for the alloxan resistant (ALR)/Lt-derived mt-Nd2
a
allele (NOD.mt
ALR) were created and compared with standard
NOD (carrying the mt-Nd2
c allele) for susceptibility to sponta-
neous autoimmune diabetes, or to diabetes elicited by reciprocal
adoptive splenic leukocyte transfers, as well as by adoptive
transfer of diabetogenic T-cell clones. -Cell lines derived from
either the NOD (NIT-1) or the NOD.mt
ALR (NIT-4) were also
created to compare their susceptibility to cytolysis by diabeto-
genic CD8
 T-cells in vitro.
RESULTS—NOD mice differing at this single SNP developed
spontaneous or adoptively transferred diabetes at comparable
rates and percentages. However, conplastic mice with the mt-
Nd2
a allele exhibited resistance to transfer of diabetes by the
CD4
 T-cell clone BDC 2.5 as well as the CD8
 AI4 T-cell clones
from T-cell receptor transgenic animals. NIT-4 cells with mt-
Nd2
a were also more resistant to AI4-mediated destruction in
vitro than NIT-1 cells.
CONCLUSIONS—Conplastic introduction into NOD mice of a
variant mt-Nd2 allele alone was not sufﬁcient to prevent sponta-
neous autoimmune diabetes. Subtle nonhematopoietic type 1
diabetes resistance was observed during adoptive transfer exper-
iments with T-cell clones. This study conﬁrms that genetic
polymorphisms in mitochondria can modulate -cell sensitivity
to autoimmune T-cell effectors. Diabetes 60:355–359, 2011
T
ype 1 diabetes is a complex disease regulated by
multiple genetic, metabolic, and environmental
factors. In both human and animal models, ge-
netic contributions to autoimmune diabetes
have been linked to loci both in the nuclear as well as in
mitochondrial genome (mtDNA) (1–5). While mtDNA poly-
morphisms can severely impair energy metabolism and
lead to diabetes (6), only a single nucleotide polymor-
phism (SNP) in the mitochondrial gene for NADH dehy-
drogenase 2 (mt-ND2) has been associated with
autoimmune diabetes in NOD mice and in humans (3–5).
Crossing the genetically related diabetes-prone NOD/
ShiLt and diabetes-resistant alloxan resistant (ALR)/Lt
mouse models (7,8) we previously mapped ALR-derived
resistance against spontaneous diabetes to three nuclear
loci and, by reciprocal outcrosses, to a mtDNA SNP in
mt-Nd2 (4). ALR mice were selected for resistance to
alloxan, a free radical generator and selective -cell toxin
(7). This selection process resulted in mice with unusually
elevated cellular defenses both systemically and at the
islet level, providing resistance to both free radicals (9,10)
and autoimmune effectors (5,11). In an additional genetic
study to deﬁne loci or genes that provided diabetes
resistance at the -cell level, the ALR-derived mt-Nd2
a
was signiﬁcantly associated with resistance against allox-
an-induced diabetes (9,12).
Sequence analysis of mtDNA revealed a SNP that distin-
guishes the ALR strain from NOD and all other strains
whose mtDNA has been sequenced (5,13). ALR mice
harboraCt oAnucleotide transversion and an amino acid
substitution from leucine to methionine (5). In humans,
there is a corresponding C to A SNP in mt-ND2 resulting in
an identical amino acid substitution. The human mt-ND2
c
allele has also been reported to persist at a higher fre-
quency in patients than control subjects (3). Allelism in
mt-ND2
a was initially proposed to alter scavenging of
reactive oxygen species (ROS) (3). However, our studies
did not substantiate a role in ROS dissipation, but rather
we have established that the resistance allele of this gene
reduces basal mitochondrial ROS production by 30%
(14,15). Hence, it might be predicted that this change in
mitochondrial ROS may signiﬁcantly alter -cell death. In
the present study, we conﬁrm that mt-Nd2
a protects
against -cell death mediated by single T-cell clones but
not against the full array of autoimmune effector
mechanisms.
RESEARCH DESIGN AND METHODS
NOD/ShiLtJ (NOD), ALR/LtJ (ALR), NOD.mt
ALR (15), and NOD.129S7(B6)-
Rag1
tm1Mom/J (NOD-Rag1) were bred in our mouse facility. Immunodeﬁ-
cient conplastic mice, NOD.mt
ALR-Rag1, were created by mating
NOD.mt
ALR females to male NOD-Rag1, followed by backcrossing to
NOD-Rag1 males and selecting mice homozygous for the disrupted allele of
Rag1. To ensure the comparability of recipients for diabetogenic T-cells,
we created an immunodeﬁcient ALR/LtJ [ALR-Rag1] by outcrossing to
NOD-Rag1 and then backcrossing for 10 generations to ALR. The congenic
interval is from D2Mit15 to D2mit190. Genotyping for Rag1
/ was
performed as described (www.jax.org). NOD.Cg-Tg(Ins2-TAg)1Lt Prkdc
scid/DvsJ
[NOD.RIP-Tag], NOD.Cg-Rag1
tm1MomTg(TcraAI4)1Dvs/DvsJ [NOD-AI4a], and
NOD.Cg-Rag1
tm1MomTg(TcrbAI4)1Dvs/DvsJ [NOD-AI4b] were purchased from
The Jackson Laboratory (Bar Harbor, ME) and bred in our mouse facility. F1
hybrid progeny from matings of NOD-AI4a with NOD-AI4b [NOD-AI4a/b]
develop diabetes at 3–5 weeks of age. All mice were housed in speciﬁc
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diabetes.diabetesjournals.org DIABETES, VOL. 60, JANUARY 2011 355pathogen-free facilities and approved by the relevant institution’s Animal Care
and Use Committee.
Monitoring for spontaneous autoimmune diabetes onset and histolog-
ical analysis. Female and male mice were monitored for diabetes onset as
previously described (4). For histological studies, pancreata were removed
from female mice and ﬁxed, embedded, and scored for insulitis as previously
described (4,11).
Adoptive transfers. Splenocytes from donor mice (diabetic female NOD,
diabetic female NOD.mt
ALR, or young [3–5 weeks old] NOD-AI4a/b F1 hybrids)
were collected, had the erythrocytes removed using hypotonic solution
treatment, and were injected intravenously (tail vein) at 2  10
7 cells/mouse
into age-matched female recipients (NOD-Rag1, ALR-Rag1 or NOD.mt
ALR-
Rag1). For BDC2.5 T-cell clone transfers (kindly provided by Dr. Katie
Haskins, University of Colorado, Denver), cells were prepared and injected as
previously described into NOD, NOD.mt
ALR, or ALR/LtJ mice (16). Mice were
followed for diabetes development after injection as described previously
(11).
Generation of -cell lines and cell-mediated lysis. A novel -cell line
NIT-4 was derived in a similar fashion to NIT-1 (17) by mating NOD.mt
ALR
females to NOD-RIP-Tag males. Islets were isolated from an 8-week-old
female F1 offspring, dissociated, and cultured in Dulbecco’s modiﬁed Eagle’s
medium modiﬁed for NIT-1 culture (17). Colonies were picked using cell
cloning rings. NIT-1 and NIT-4 cells were genotyped for mt-Nd2 by pyrose-
quencing as described previously (5) (supplementary Fig. 1 in the online
appendix available at http://diabetes.diabetesjournals.org/cgi/content/full/
db10-1241/DC1). For the included experiments, NIT-1 and NIT-4 cells were
used at passage numbers P11-P20 and cultured as described (17). To test the
sensitivity of -cell lines to killing by AI4 T-cells in vitro, cell-mediated lysis
(CML) assays were performed and calculated as described previously (18).
Statistical analysis. Survival analysis and Student t test were performed
using Prizm-v5a (GraphPad Software, LaJolla, CA).
RESULTS
The mt-Nd2
a allele alone does not affect the overall
incidence of spontaneous diabetes in NOD mice. Com-
parable rates of type 1 diabetes incidence were recorded
for NOD and NOD.mt
ALR (Fig. 1). Although there was a
trend toward slower incidence in male NOD.mt
ALR, the
difference was not signiﬁcant. A study of insulitis develop-
ment in female NOD and NOD.mt
ALR mice from 4 to 16
weeks of age was also performed. Consistent with diabe-
tes incidence, there were no differences in the histological
scores comparing age-matched NOD with NOD.mt
ALR
mice (data not shown).
Adoptive transfer of splenic leukocytes. To identify
effects of mt-Nd2
a on immune functions versus an effect
on pancreatic -cells, reciprocal adoptive transfers were
performed. Donors were either diabetic NOD females or
diabetic NOD.mt
ALR females. All recipients were age-
matched immunodeﬁcient Rag1
/ females separately ex-
pressing each mt-Nd2 allotype. Neither allotype expressed
by mitochondria in splenocytes from diabetic donors
signiﬁcantly affected adoptive transfer (Fig. 2). Similarly,
the mt-Nd2 allotype expressed by the recipients had no
signiﬁcant effect on the adoptive transfer kinetics regard-
less of the allotype expressed by the transferred leuko-
cytes. Thus, in the absence of other ALR-protective
nuclear genes, the ALR-derived mt-Nd2
a allele cannot
deviate the attack mediated by the plethora of autoreac-
tive T-cells present in spleens of diabetic donors.
Adoptive transfer study using diabetogenic CD8

T-cells. All NOD-Rag1 recipients developed diabetes after
transfer of activated AI4a/b CD8
 T-cells (Fig. 3A). Not
surprisingly, ALR-Rag1 mice were resistant to disease
transfer by AI4 T-cells (Fig. 3A), consistent with published
data showing that ALR/LtJ islets resist lysis by AI4 cells
(11). NOD.mt
ALR-Rag1 mice, although clearly susceptible
to AI4-mediated diabetes transfer, nevertheless exhibited
a statistically signiﬁcant retardation in disease develop-
ment compared with NOD-Rag1 controls (P  0.0036).
Thus, when the T-cell attack is limited to recognition of a
single -cell autoantigen (AI4 recognizes an epitope of
dystonia myotonica kinase), the ALR-derived mitochon-
drial genome confers some resistance, albeit incomplete in
the absence of additional protective ALR-derived nuclear
genes.
CML. The only known genetic difference between NIT-1
and NIT-4 cell lines is the derivation of the mitochondrial
population from ALR/Lt in the latter line. SNP typing has
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FIG. 1. There is no signiﬁcant difference in spontaneous type 1
diabetes incidence in either female (A) or male (B) NOD mice (mt-Nd2
c
allele) compared with NOD.mt
ALR conplastic mice with the ALR-de-
rived mt-Nd2
a allele. Incidence studies were performed independently
at The Jackson Laboratory and The Children’s Hospital of Pittsburgh
using both female and male NOD and NOD.mt
ALR conplastic mice.
These two studies obtained equivalent incidence results, and the
combined analysis is presented.
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FIG. 2. Reciprocal adoptive transfers (ATs) were performed into
immunodeﬁcient NOD-Rag1 females expressing either mt-Nd2 allele
as recipients and splenic leukocytes from diabetic NOD or diabetic
conplastic donors (NOD.mt
ALR). Splenocytes from these donor mice
were collected and erythrocytes removed using hypotonic solution
treatment. Cells were injected intravenously (tail vein) at 2  10
7
cells/mouse into age-matched female recipients. The source of the
mitochondrial population in either diabetic donor splenocytes or in
Rag1 recipients did not signiﬁcantly affect rate of diabetes develop-
ment in NOD recipients.
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a allele and NIT-1
has the mt-Nd2
c allele (supplementary Fig. 1). NIT-1 cells
were killed by activated AI4a/b CD8
 T-cells in a dose-
dependent fashion whereas NIT-4 cells were resistant (Fig.
3B). Live cell confocal microscopy time series conﬁrmed
the susceptibility of NIT-1 cells to AI4-mediated killing as
well as the resistance of NIT-4 cells to AI4-mediated lysis
(supplementary Videos 2–5). However, priming NIT-4 cells
with -interferon (IFN-) for 24 h before adding AI4-
effector cells resulted in heightened sensitivity. We ob-
served no statistical difference comparing the CML results
of IFN-–treated NIT-1 and NIT-4 cells (Fig. 3C).
Adoptive transfer of cloned diabetogenic BDC2.5
CD4
 T-cell clones. The diabetogenic CD4
 T-cell clone
BDC2.5 transferred diabetes to all NOD mice within 5 days
(Fig. 4). In marked contrast to NOD mice, all ALR and
NOD.mt
ALR mice remained diabetes free after transfer of
BDC2.5 cells for the 28-day follow-up period. This con-
ﬁrms that when the T-effector population is limited to a
single -cell autoantigen a signiﬁcant contribution to re-
sistance can be demonstrated.
DISCUSSION
Autoimmune diabetes is a polygenic disease. Major histo-
compatibility complex (MHC) and numerous non-MHC
IDD/type 1 diabetes/Idd loci have been mapped in humans
as well as rat and mouse models (rev. in 2). However,
although multiple type 1 diabetes susceptibility and resis-
tance loci have been identiﬁed, only a few of the respon-
sible genes have been identiﬁed, and for the genes
identiﬁed as responsible, the mechanism of action has yet
to be elucidated. Using backcross and F2 hybrid breeding
strategies in mouse models, we mapped the A allele of a
SNP in the mitochondrially encoded mt-Nd2 gene as
protective against both autoimmune and alloxan-induced
free radical–mediated diabetes. These data suggested that
the mt-Nd2
a allotype provided protection at the -cell
level with ROS resistance as a potential mechanism (14).
The current ﬁnding that substitution of the NOD allotype
with its protective ALR/Lt counterpart failed to prevent
spontaneous diabetes in NOD.mt
ALR mice (Fig. 1) is con-
sistent with our previous observation with the alloxan
model (9). This is not surprising given the complexity of
autoimmune diabetes. In both the autoimmune (4) and
alloxan-induced diabetes models (9), we identiﬁed multi-
ple resistance loci, including mt-Nd2
a. The speciﬁc inter-
action of mt-Nd2
a with nuclear loci would provide a
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FIG. 3. The mt-Nd2
a allele confers resistance to killing by diabetogenic
CD8
 AI4 T-cells in vivo and in vitro. A: Type 1 diabetes onset is
signiﬁcantly retarded following A14 transfer into Rag1 recipients
conplastic for the mt-ND2
a allele (NOD.mt
ALR-Rag). Splenocytes from
young (3–5 weeks old) NOD-AI4a/b F1 hybrids were collected and
erythrocytes removed using hypotonic solution treatment. Cells were
injected intravenously (tail vein) at 2  10
7 cells/mouse into age-
matched female recipients. Onset of diabetes was monitored using
Diastix, with a diagnosis of type 1 diabetes called after positive tests
on 2 sequential days. B and C: AI4-induced CML is signiﬁcantly
reduced in NIT-4 cells compared with NIT-1 cells in vitro. Effector
cells, splenocytes from NOD-AI4a/b F1 mice were isolated, erythro-
cytes removed, and the T-cells activated for 3 days with 0.1 mol/l AI4
mimotope (amino acid sequence YFIENYLEL) and 25 units/ml interleu-
kin-2 in RPMI1640 supplemented with 10% FBS, 2 mmol/l L-glutamine,
1.5g/l sodium bicarbonate, 10 mmol/l HEPES, and 1.0 mmol/l sodium
pyruvate. Target NIT-1 and NIT-4 cells were seeded at 1  105
cells/well in 96-well culture plates, labeled with 51Cr (Perkin Elmer)
for 3 h, and washed; then activated AI4-effector cells were added at
increasing effector-to-target (E:T) ratios, in triplicate. B: Cr-51–la-
beled NIT-1 and NIT-4 cells were cultured with preactivated AI4 cells
at different E:T ratio for 16 h. Speciﬁc lysis of NIT-4 cells at the highest
E:T ratio is only 40% that of NIT-1. C: NIT-1 and NIT-4 cells were
primed with 1,000 U/ml IFN- for 24 h before adding T-cells. Both cell
types were more sensitive to AI4 T-cell killing compared with
unprimed. At the highest E:T ratio, NIT-4–speciﬁc lysis reached 61%
that of NIT-1. **P  0.0009; *P  0.0048. AT, adoptive transfer; NS, not
statistically signiﬁcant.
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FIG. 4. NOD-mt
ALR mice are completely resistant to type 1 diabetes
mediated by transfer of diabetogenic CD4
 T-cell clone BDC2.5.
BDC2.5 T-cell clones were injected into NOD, NOD.mt
ALR, or ALR/LtJ
mice. Development of diabetes after injection was monitored using
Diastix, with a diagnosis of type 1 diabetes called after positive tests
on 2 sequential days. AT, adoptive transfer.
J. CHEN AND ASSOCIATES
diabetes.diabetesjournals.org DIABETES, VOL. 60, JANUARY 2011 357model to study genetic interactions between the two
cellular genomes—nuclear and mitochondrial.
Because protection against diabetes was not observed
when the mt-Nd2 SNP was substituted with its protective
counterpart, we assessed subphenotypes in which this
SNP could inﬂuence disease. Immune cell proﬁles were
strikingly similar when comparing the two strains (supple-
mentary Fig. 2), suggesting that this SNP does not affect
immune cell development. To isolate any effect of this SNP
within immune cells, we used reciprocal adoptive trans-
fers. These transfer experiments demonstrated no statis-
tically signiﬁcant differences in diabetes onset (Fig. 2),
suggesting that this SNP does not affect immune cell
function. However, when we challenged mice with single
diabetogenic T-cell clones (either the CD8
 AI4 or the CD4

BDC2.5), mice with the mt-Nd2
a allele responded differ-
ently than those with the mt-Nd2
c allele. NOD.mt
ALR-Rag1
mice were more resistant to disease onset after the
transfer of either diabetogenic T-cell clonotype (Figs. 3
and 4), suggesting this SNP modiﬁes type 1 diabetes
through nonhematopoietic factors.
CD8
 cytotoxic T-lymphocytes destroy pancreatic
-cells directly by recognition of autoantigens in the
context of class I MHC and initiation of cytotoxicity by
fatty acid synthase (FAS)-Ligand/FAS pathways and re-
lease of granzyme and perforin (19). Subtle changes in
mitochondrial pathways downstream of these death path-
ways may explain the partial resistance to transfer of
diabetes by AI4 T-cells to mt-Nd2
a encoding NOD-mt
ALR-
Rag1 mice. Likewise, when preactivated diabetogenic
CD8
 AI4 T-cells were combined with -cells in vitro the
NOD-derived -cell line NIT-1 was killed (Fig. 3B and
supplementary Video 2), yet NIT-4 with the mt-Nd2
a allele
were resistant (Fig. 3B and supplementary Video 4).
Resistance was eliminated when target -cell lines were
primed with IFN- before adding AI4 cells (Fig. 3C). IFN-
priming induces MHC class I and FAS on the -cell surface
(20). The change that mt-Nd2
a exerts on mitochondrial
function through ROS modulation may alter ROS-depen-
dent signaling of death receptor pathways as manifested
as resistance of NIT-4 to autoreactive CD8
 AI4 cells in
vitro and retarded disease transfer by AI4 in vivo. How-
ever, the resistance conferred by this SNP at the -cell
level is overridden by IFN- priming.
Unlike CD8
 T-cells, BDC2.5 CD4
 T-cells do not di-
rectly kill -cells, such that killing is cytokine-dependent
(21). Upon transfer into recipient mice, BDC2.5 T-cells
require activation to initiate pancreatic -cell destruction.
-Cell expression of tumor necrosis factor (TNF) receptor
1(TNFR1)-P50 is critical for activation of BDC2.5 cells
(22). When these diabetogenic CD4
 T-cells were trans-
ferred to recipient mice, endogenous macrophages were
recruited to the pancreas and activated to secrete cyto-
kines (21). These cytokines include TNF-. TNF- induces
both apoptosis and necrosis of cells through the TNFR1
(rev. in 23). During TNFR-induced cell death, mitochon-
dria participate in a series of events including generating
truncated BID locally, releasing cytochrome C, activating
downstream caspases, and producing ROS (23). ROS
production by mitochondria is an early event in TNFR-
induced cell death (23). Therefore, mitochondrial partici-
pation through ROS production is likely indispensable in
BDC2.5-mediated -cell killing. The fact that a ROS scav-
enger inhibits the transfer of diabetes by BDC 2.5 clones
(16) implicates ROS as mediators of -cell death induced
by BDC2.5.
In the current study, a substitution of a SNP in mito-
chondrially encoded mt-Nd2 cannot alter the overall spon-
taneous diabetes in NOD mice. However, subtle changes
caused by this SNP (15) account for the greater resistance
of the NOD.mt
ALR mice to BDC2.5 and AI4-mediated
diabetes. In conclusion, this study conﬁrms that genetic
polymorphisms in mitochondria can modulate -cell sen-
sitivity to autoimmune T-cell effectors and raises the
possibility that the mt-ND2
a allotype in humans may
provide similar protection.
ACKNOWLEDGMENTS
This work was supported by National Institutes of Health
grants DK074656 and AI56374 (to C.E.M.), DK36175 and
DK27722 (to E.H.L.), as well as by grants from the Juvenile
Diabetes Research Foundation.
No potential conﬂicts of interest relevant to this article
were reported.
J.C. and C.E.M. designed the research plan, performed
experiments, analyzed data, and wrote the manuscript.
A.M.G. performed experiments and revised the manu-
script. J.P. performed the BDC2.5 adoptive transfers.
E.H.L. participated in the experimental design and edited
the manuscript.
Parts of this study were presented in abstract form at
the 70th Scientiﬁc Sessions of the American Diabetes
Association, Orlando, Florida, 25–29 June 2010.
REFERENCES
1. Concannon P, Rich SS, Nepom GT. Genetics of type 1A diabetes. N Engl
J Med 2009;360:1646–1654
2. Thayer TC, Wilson SB, Mathews CE. Use of nonobese diabetic mice to
understand human type 1 diabetes. Endocrinol Metab Clin North Am
2010;39:541–61
3. Uchigata Y, Okada T, Gong JS, Yamada Y, Iwamoto Y, Tanaka M. A
mitochondrial genotype associated with the development of autoimmune-
related type 1 diabetes. Diabetes Care 2002;25:2106
4. Mathews CE, Graser RT, Bagley RJ, Caldwell JW, Li R, Churchill GA,
Serreze DV, Leiter EH. Genetic analysis of resistance to Type-1 Diabetes in
ALR/Lt mice, a NOD-related strain with defenses against autoimmune-
mediated diabetogenic stress. Immunogenetics 2003;55:491–496
5. Mathews CE, Leiter EH, Spirina O, Bykhovskaya Y, Gusdon AM, Ringquist
S, Fischel-Ghodsian N. mt-Nd2 Allele of the ALR/Lt mouse confers
resistance against both chemically induced and autoimmune diabetes.
Diabetologia 2005;48:261–267
6. Maassen JA, ‘T Hart LM, Van Essen E, Heine RJ, Nijpels G, Jahangir
Tafrechi RS, Raap AK, Janssen GM, Lemkes HH. Mitochondrial diabetes:
molecular mechanisms and clinical presentation. Diabetes 2004;53(Suppl
1):S103–S109
7. Ino T, Kawamoto Y, Sato K, Nishikawa K, Yamada A, Ishibashi K, Sekiguchi
F. Selection of mouse strains showing high and low incidences of
alloxan-induced diabetes. Jikken Dobutsu 1991;40:61–67
8. Makino S, Kunimoto K, Muraoka Y, Mizushima Y, Katagiri K, Tochino Y.
Breeding of a non-obese, diabetic strain of mice. Jikken Dobutsu 1980;29:
1–13
9. Chen J, Lu Y, Lee CH, Li R, Leiter EH, Mathews CE. Commonalities of
genetic resistance to spontaneous autoimmune and free radical–mediated
diabetes. Free Radic Biol Med 2008;45:1263–1270
10. Mathews CE, Leiter EH. Constitutive differences in antioxidant defense
status distinguish alloxan-resistant and alloxan-susceptible mice. Free
Radic Biol Med 1999;27:449–455
11. Mathews CE, Graser RT, Savinov A, Serreze DV, Leiter EH. Unusual
resistance of ALR/Lt mouse beta cells to autoimmune destruction: role for
beta cell-expressed resistance determinants. Proc Natl Acad SciUSA
2001;98:235–240
12. Chen J, Gusdon AM, Thayer TC, Mathews CE. Role of increased ROS
dissipation in prevention of T1D. Ann N Y Acad Sci 2008;1150:157–166
13. Yu X, Gimsa U, Wester-Rosenlo ¨f L, Kanitz E, Otten W, Kunz M, Ibrahim SM.
Dissecting the effects of mtDNA variations on complex traits using mouse
conplastic strains. Genome Res 2009;19:159–165
14. Gusdon AM, Votyakova TV, Mathews CE. mt-Nd2a suppresses reactive
mt-Nd2
a PROTECTS -CELLS FROM AUTOIMMUNITY
358 DIABETES, VOL. 60, JANUARY 2011 diabetes.diabetesjournals.orgoxygen species production by mitochondrial complexes I and III. J Biol
Chem 2008;283:10690–10697
15. Gusdon AM, Votyakova TV, Reynolds IJ, Mathews CE. Nuclear and
mitochondrial interaction involving mt-Nd2 leads to increased mitochon-
drial reactive oxygen species production. J Biol Chem 2007;282:5171–5179
16. Piganelli JD, Flores SC, Cruz C, Koepp J, Batinic-Haberle I, Crapo J, Day B,
Kachadourian R, Young R, Bradley B, Haskins K. A metalloporphyrin-
based superoxide dismutase mimic inhibits adoptive transfer of autoim-
mune diabetes by a diabetogenic T-cell clone. Diabetes 2002;51:347–355
17. Hamaguchi K, Gaskins HR, Leiter EH. NIT-1, a pancreatic beta-cell line
established from a transgenic NOD/Lt mouse. Diabetes 1991;40:842–849
18. Takaki T, Marron MP, Mathews CE, Guttmann ST, Bottino R, Trucco M,
DiLorenzo TP, Serreze DV. HLA-A*0201-restricted T cells from humanized
NOD mice recognize autoantigens of potential clinical relevance to type 1
diabetes. J Immunol 2006;176:3257–3265
19. Dudek NL, Thomas HE, Mariana L, Sutherland RM, Allison J, Estella E,
Angstetra E, Trapani JA, Santamaria P, Lew AM, Kay TW. Cytotoxic T-cells
from T-cell receptor transgenic NOD8.3 mice destroy beta-cells via the
perforin and Fas pathways. Diabetes 2006;55:2412–2418
20. Thomas HE, Darwiche R, Corbett JA, Kay TW. Evidence that beta cell
death in the nonobese diabetic mouse is Fas independent. J Immunol
1999;163:1562–1569
21. Peterson JD, Berg R, Piganelli JD, Poulin M, Haskins K. Analysis of
leukocytes recruited to the pancreas by diabetogenic T cell clones. Cell
Immunol 1998;189:92–98
22. Pakala SV, Chivetta M, Kelly CB, Katz JD. In autoimmune diabetes the
transition from benign to pernicious insulitis requires an islet cell response
to tumor necrosis factor alpha. J Exp Med 1999;189:1053–1062
23. Van Herreweghe F, Festjens N, Declercq W, Vandenabeele P. Tumor
necrosis factor-mediated cell death: to break or to burst, that’s the
question. Cell Mol Life Sci 2010;67:1567–1579
J. CHEN AND ASSOCIATES
diabetes.diabetesjournals.org DIABETES, VOL. 60, JANUARY 2011 359